• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Laparoscopic versus open splenectomy in the treatment of idiopathic thrombocytopenic purpura: an Indian experience.

作者信息

Ray Udipta, Gupta Shahana, Chatterjee Shamita, SenGupta Tamal Kanti, Gupta Naveen Kumar

机构信息

Department of General Surgery, NRS Medical College and Hospital, Kolkata 700073.

出版信息

J Indian Med Assoc. 2012 Dec;110(12):889-93.

PMID:23936952
Abstract

UNLABELLED

Laparoscopic splenectomy (LS) is emerging as the treatment of choice over open splenectomy (OS) in cases of idiopathic (immune) thrombocytopenic purpura (ITP) that is either steroid resistant or steroid unresponsive.The aim of the present study is to compare therapeutic response and outcome of patients with ITP undergoing LS with a similar group undergoing OS.The study was performed on 63 patients with ITP attending Medical College and Hospital, Kolkata, a tertiary level referral centre in Eastern India during 2005-2009.Twenty-seven patients with ITP underwent LS and the rest underwent OS. Twenty-eight patients were steroid resistant whereas the rest were diagnosed to be refractory to steroids. Parameters assessed were demographic characteristics of patients, peri-operative data, complications and haematological outcome.The patients were followed up for a mean period of 40 months.

RESULTS

Demographic characteristics of the patients in LS and OS group were comparable. Patients undergoing LS were found to require a longer operative time but had lower intra-operative blood loss, less postoperative pain, decreased incidence of complications, reduced hospital stay and comparable haematological response as compared to that for patients undergoing OS. LS for ITP is a safe technique associated with lower morbidity and faster convalescence and similar haematological response when compared to OS.

摘要

相似文献

1
Laparoscopic versus open splenectomy in the treatment of idiopathic thrombocytopenic purpura: an Indian experience.
J Indian Med Assoc. 2012 Dec;110(12):889-93.
2
[Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura].[腹腔镜脾切除术治疗免疫性血小板减少性紫癜的介绍]
Zentralbl Chir. 2004 Apr;129(2):108-13. doi: 10.1055/s-2004-818730.
3
Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP).腹腔镜脾切除术治疗特发性血小板减少性紫癜(ITP)。
Surg Endosc. 2003 Jan;17(1):95-8. doi: 10.1007/s00464-002-8805-y. Epub 2002 Sep 23.
4
Laparoscopic or open splenectomy for hematologic disease: which approach is superior?用于血液系统疾病的腹腔镜或开放性脾切除术:哪种方法更具优势?
J Am Coll Surg. 1997 Jul;185(1):49-54.
5
Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution.教学医院腹腔镜脾切除术治疗免疫性血小板减少性紫癜。
Chin Med J (Engl). 2011 Apr;124(8):1175-80.
6
Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: clinical and economic analysis.开放性与腹腔镜脾切除术治疗特发性血小板减少性紫癜:临床与经济学分析
Surgery. 2003 Jul;134(1):45-52. doi: 10.1067/msy.2003.204.
7
Efficacy and safety of laparoscopic splenectomy: review of 14 adult cases using the lateral approach.腹腔镜脾切除术的疗效与安全性:14例成人病例经外侧入路的回顾
Bol Asoc Med P R. 2009 Apr-Jun;101(2):43-9.
8
Laparoscopic splenectomy for idiopathic thrombocytopenic purpura.腹腔镜脾切除术治疗特发性血小板减少性紫癜
Am J Surg. 2004 Jun;187(6):720-3. doi: 10.1016/j.amjsurg.2003.11.032.
9
Laparoscopic splenectomy for immune thrombocytopenic purpura.腹腔镜脾切除术治疗免疫性血小板减少性紫癜。
S Afr J Surg. 2013 May 3;51(2):54-6. doi: 10.7196/sajs.1325.
10
Laparoscopic versus open splenectomy: a comparative study.腹腔镜与开放性脾切除术:一项对比研究。
Surg Laparosc Endosc Percutan Tech. 2000 Oct;10(5):291-5.

引用本文的文献

1
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.